Advertisement
外匯新聞
Dollar Gains Against Major Rivals, Climbs To Fresh Near 2-decade High
The U.S. dollar climbed higher against its major rivals on Monday, with investors looking ahead to the crucial inflation data due later in the week, and betting on hopes the Federal Reserve will continue with its policy tightening moves.
RTTNews |
1122天前
Canadian Market Remains In Negative Territory, Headed For Another Weak Close
The Canadian market remains firmly down in negative territory Monday afternoon with stocks from several sectors reeling under sustained selling pressure.
RTTNews
|
1122天前
Swiss Market Ends Slightly Higher
After a weak start, the Switzerland stock market recovered well, but stayed below the flat line almost right through the session on Monday, as investors stayed cautious and largely refrained from making significant moves.
RTTNews
|
1122天前
European Stocks Close Weak After Cautious Session
European stocks closed on a weak note on Monday as worries about corporate earnings outlook, energy crisis following Russia turning off Nord Stream 1, and fresh Covid-19 curbs in China weighed on sentiment.
RTTNews
|
1122天前
U.S. Dollar Higher With Inflation Data In Focus
The U.S. dollar advanced against its major counterparts in the European session on Monday, as investors awaited U.S. inflation data due this week, after strong jobs data supported expectations for the aggressive policy tightening path by the Federal Reserve.
RTTNews
|
1123天前
T2 Biosystems Says FDA Grants Breakthrough Device Designation For T2Lyme Panel
T2 Biosystems, Inc. (TTOO) announced Monday the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Company's T2Lyme Panel.
RTTNews
|
1123天前
Vail Resorts CFO Michael Barkin To Step Down
Vail Resorts, Inc. (MTN) announced Monday that Executive Vice President and Chief Financial Officer Michael Barkin will be stepping down after nearly a decade in role to take time to pursue personal opportunities.
RTTNews
|
1123天前
more news
Arcutis Says Health Canada Accepts For Review Roflumilast Cream NDS For Plaque Psoriasis
Arcutis Biotherapeutics, Inc. (ARQT) announced Monday that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in adults and adolescents. The target action date is April 30, 2023.
RTTNews
|
1123天前
Lipocine Says FDA Oks LPCN 2101 IND For Adult Epilepsy Treatment
Biopharmaceutical company Lipocine Inc. (LPCN) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a potential treatment for adults with epilepsy.
RTTNews
|
1123天前
Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash
Vertex Pharmaceuticals Inc. (VRTX) announced Monday that the company has entered into a definitive agreement under which Vertex will acquire privately-held biotechnology company ViaCyte for $320 million in cash.
RTTNews
|
1123天前
Bay Street Seen Opening On Negative Note
Lower futures and falling commodity prices point to a weak start for the Canadian stock market on Monday. Worries about a surge in coronavirus cases and fresh curbs in China are also likely to weigh.
RTTNews
|
1123天前
Perrigo Says HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The U.S.
Consumer Self-Care Products firm Perrigo Co. plc (PRGO) announced Monday that its company HRA Pharma has submitted its application to the U.S. Food and Drug Administration (FDA) for the first-ever over-the-counter (OTC) birth control pill in the U.S.
RTTNews
|
1123天前
Australian Dollar Drops Amid Risk Aversion
The Australian dollar fell against its most major counterparts in the European session on Monday, as a rise in COVID-19 cases in China and the energy crisis in Europe dampened risk sentiment.
RTTNews
|
1123天前
Stay up to date!
Add 新聞 to your browser
Add To Chrome
